Two vaccine makers have said that preliminary results from their late-stage studies suggest their experimental vaccines are strongly protective. Moderna this week said its vaccine appears nearly 95 per cent effective.
Read More
It's the second time this month that a company unveiled such encouraging numbers about a vaccine, boosting hopes that the global economy can return to some semblance of normal next year.
Read More
Another $5 billion will also be needed in 2021 to procure COVID-19 vaccine doses as they come through development and are approved by regulators
Read More
The company had posted a net profit of Rs 117.7 crore for the corresponding period of the previous fiscal, Natco Pharma said in a BSE filing.
Read More
Tacrolimus capsule is an immunosuppressant and is used for preventing organ rejection in certain patients following liver, kidney, or heart transplant.
Read More
The government has increased the number of beds for COVID-19 patients in hospitals in Delhi, but there is no plan to rope in hotels and banquet halls
Read More
The medicine, approved as Ilaris for juvenile arthritis and other conditions, also did not meet its key secondary endpoint of reducing COVID-19 mortality in a late-phase clinical trial
Read More
While AstraZeneca marches on with the vaccine, demand for its diverse portfolio of drugs remained strong despite disruptions to health systems due to the pandemic.
Read More
